India, April 22 -- Merck, a leading science and technology company, has announced the launch of the first bio-based solvent portfolio specifically for high-performance liquid chromatography (HPLC). Manufactured using renewable feedstocks, these new patent-pending solvents deliver on average 25.9% lower CO2 equivalents compared to conventional fossil-fuel-based HPLC-grade solvents, while preserving the performance required for demanding analytical workflows.

"Our new bio-based HPLC solvents represent the next generation of high-performance liquid chromatography," said Karen Madden, Chief Technology Officer, Life Science business of Merck. "Customers are looking for solutions that help reduce environmental impact without com...